Staying on target in gene and cell therapy
Mol Ther
.
2024 Sep 4;32(9):2801-2802.
doi: 10.1016/j.ymthe.2024.08.010.
Epub 2024 Aug 23.
Authors
Rory Bricker-Anthony
1
,
Dwight D Koeberl
2
,
Gerald S Lipshutz
3
,
Fabiana Perna
4
Affiliations
1
Scientific Editor, Molecular Therapy family of journals. Electronic address:
[email protected]
.
2
Department of Pediatrics, Duke University School of Medicine, Duke University Medical Center, Durham, NC, USA.
3
David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
4
Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, USA.
PMID:
39178850
PMCID:
PMC11403208
(available on
2025-09-04
)
DOI:
10.1016/j.ymthe.2024.08.010
No abstract available
Publication types
Editorial
MeSH terms
Cell- and Tissue-Based Therapy* / methods
Genetic Therapy* / methods
Humans